Differential p38 mitogen-activated protein kinase target phosphorylation in responders and nonresponders to infliximab

Gastroenterology. 2003 Aug;125(2):633-4; author reply 635-6. doi: 10.1016/s0016-5085(03)00979-x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Activating Transcription Factor 2
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / drug therapy*
  • Crohn Disease / metabolism
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Female
  • HSP27 Heat-Shock Proteins
  • Heat-Shock Proteins*
  • Humans
  • Hydrazones / pharmacology
  • Infliximab
  • Male
  • Mitogen-Activated Protein Kinases / metabolism*
  • Molecular Chaperones
  • Neoplasm Proteins / metabolism
  • Phosphorylation
  • Transcription Factors / metabolism
  • Tumor Necrosis Factor-alpha / physiology*
  • p38 Mitogen-Activated Protein Kinases

Substances

  • Activating Transcription Factor 2
  • Antibodies, Monoclonal
  • Cyclic AMP Response Element-Binding Protein
  • HSP27 Heat-Shock Proteins
  • HSPB1 protein, human
  • Heat-Shock Proteins
  • Hydrazones
  • Molecular Chaperones
  • Neoplasm Proteins
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • semapimod
  • Infliximab
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases